We are live on ! Find out more

2,108 hedge funds and large institutions have $110B invested in Amgen in 2019 Q4 according to their latest regulatory filings, with 318 funds opening new positions, 669 increasing their positions, 839 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

397% more first-time investments, than exits

New positions opened: 318 | Existing positions closed: 64

81% more funds holding in top 10

Funds holding in top 10: 62112 (+50)

23% more capital invested

Capital invested by funds: $89.4B → $110B (+$20.6B)

12% more funds holding

Funds holding: 1,8842,108 (+224)

0.19% less ownership

Funds ownership: 77.17%76.98% (-0.19%)

20% less repeat investments, than reductions

Existing positions increased: 669 | Existing positions reduced: 839

21% less call options, than puts

Call options by funds: $1.49B | Put options by funds: $1.88B

Holders
2,108
Holders Change
+224
Holders Change %
+11.89%
% of All Funds
41.53%
Holding in Top 10
112
Holding in Top 10 Change
+50
Holding in Top 10 Change %
+80.65%
% of All Funds
2.21%
New
318
Increased
669
Reduced
839
Closed
64
Calls
$1.49B
Puts
$1.88B
Net Calls
-$387M
Net Calls Change
-$105M
Name Holding Trade Value Shares
Change
Change in
Stake
Public Sector Pension Investment Board (PSP Investments)
201
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$42.9M +$13.5M +61,358 +53%
FAF
202
Fjarde Ap-fonden
Sweden
$42M +$860K +3,900 +2%
VDI
203
Vaughan David Investments
Illinois
$41.6M -$196K -888 -0.5%
KBC Group
204
KBC Group
Belgium
$41.5M -$2.94M -13,321 -7%
WCM
205
Wedge Capital Management
North Carolina
$41.4M -$881K -3,996 -2%
H
206
Hexavest
Quebec, Canada
$39M -$689K -3,127 -2%
Calamos Advisors
207
Calamos Advisors
Illinois
$38.4M -$274K -1,241 -0.8%
MIM
208
MetLife Investment Management
New Jersey
$38.1M -$1.18M -5,356 -3%
Mirae Asset Global Investments
209
Mirae Asset Global Investments
South Korea
$37.8M +$3.87M +17,534 +13%
Parallax Volatility Advisers
210
Parallax Volatility Advisers
California
$37.1M +$1.33M +6,016 +4%
AIM
211
Artemis Investment Management
United Kingdom
$37.1M -$1.01M -4,602 -3%
Janus Henderson Group
212
Janus Henderson Group
United Kingdom
$36.5M -$20.9M -94,740 -39%
PFM
213
Parsec Financial Management
North Carolina
$36.4M -$235K -1,065 -0.7%
AII
214
AGF Investments Inc
Ontario, Canada
$36.3M
NIPH
215
NN Investment Partners Holdings
Netherlands
$35.3M +$10.9M +49,311 +51%
XK
216
Xact Kapitalforvaltning
Sweden
$35.3M -$847K -3,841 -3%
NC
217
Nicholas Company
Wisconsin
$35.1M -$5.51K -25 -0%
OPERF
218
Oregon Public Employees Retirement Fund
Oregon
$34.7M +$621K +2,815 +2%
IR
219
IAT Reinsurance
New York
$34.4M -$551K -2,500 -2%
GIBU
220
Gulf International Bank (UK)
United Kingdom
$34.3M -$865K -3,925 -3%
BCIM
221
British Columbia Investment Management
British Columbia, Canada
$34.1M -$3.52M -15,981 -10%
USAA
222
United Services Automobile Association
Texas
$33.4M -$635K -2,879 -2%
GAM
223
Gotham Asset Management
New York
$33.2M +$19.4M +88,088 +177%
Mitsubishi UFJ Asset Management
224
Mitsubishi UFJ Asset Management
Japan
$32.9M +$3.08M +13,995 +11%
PAM
225
Panagora Asset Management
Massachusetts
$32.8M +$27.1M +122,866 +924%

AMGN Hedge Fund Activity: Q4 2019 in Review

2,108 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2019, worth a combined $110B — up 23% from $89.4B a quarter earlier.

Buyers outnumbered sellers: 318 funds opened new AMGN positions and 64 closed out — a net gain of 254 holders — while 669 added to existing stakes and 839 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $453M. The largest seller was Invesco, cutting an estimated $1.22B.

  • 2,108 institutional investors held Amgen (AMGN) as of Q4 2019, up from 1,884 in Q3 2019.
  • Funds reported $110B of Amgen stock for Q4 2019, up 23% quarter-over-quarter.
  • 318 funds opened new Amgen positions in Q4 2019 and 64 closed out, a net change of +254 holders.
  • The largest Amgen buyer in Q4 2019 was JP Morgan Chase, an estimated $453M added.
  • The largest Amgen seller in Q4 2019 was Invesco, an estimated $1.22B sold.

Based on aggregated 13F filings for Q4 2019.